Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.
Authors
Heloisa P. Soares
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Heloisa P. Soares , Katherine A Guthrie , Syed A. Ahmad , Mary Kay Washington , Brian Hemendra Ramnaraign , Nitya Prabhakar Raj , Carole Seigel , Shay Bellasea , E. Gabriela Chiorean , Arvind Dasari , Jonathan R. Strosberg , Cathy Eng , Philip Agop Philip
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT05040360
DOI
10.1200/JCO.2022.40.4_suppl.TPS515
Abstract #
TPS515
Poster Bd #
P6
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.
First Author: Robert Lance Fine
Poster
2022 ASCO Annual Meeting
Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.
First Author: Jennifer Rachel Eads
Poster
2017 Gastrointestinal Cancers Symposium
Pancreatic neuroendocrine tumors: A population-based analysis of epidemiology and outcomes.
First Author: Samer Alsidawi
Poster
2015 Gastrointestinal Cancers Symposium
BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs).
First Author: Nitya Prabhakar Raj